Sleep drug labels to address adverse reactions.(News): An article from: Skin & Allergy News

This digital document is an article from Skin & Allergy News, published by Thomson Gale on May 1, 2007. The length of the article is 743 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Sleep drug labels to address adverse reactions.(News)
Author: Elizabeth Mechcatie
Publication:

List Price: $ 9.95

Price: $ 9.95

Hydroxyzine (Vistaril, Atarax)


Image by Divine Harvester
A first-generation antihistamine of the diphenylmethane and piperazine classes. It was first synthesized by Union Chimique Belge in 1956 and was marketed by Pfizer in the United States later the same year, and is still in widespread use today.

Hydroxyzine is used primarily as an antihistamine for the treatment of itching, allergies, hyperalgesia, motion sickness-induced nausea, and insomnia, as well as notably for the treatment of mild anxiety. Even though it is an effective sedative, hypnotic, analgesic, and tranquilizer, it shares almost none of the abuse, dependence, addiction, and toxicity potential of other drugs used for the same range of therapeutic reasons.[citation needed]

Hydroxyzine is used with opioid analgesics to increase the pain-killing ability of a given dose of opioid, reduce the quantity needed to stop a given level of pain, and/or preempt some side effects of opioids like itching, nausea, and vomiting.

Find More Allergy Side Effects Products